Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 27, 2018
STRATA Skin Sciences, Inc. to Report Fiscal 2017 Financial Results on Thursday, March 29
HORSHAM, Pa., March 27, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to ...
March 27, 2018
Krystal Submits Investigational New Drug (IND) Application for KB103, Topical Gene Therapy Candidate for Dystrophic Epidermolysis Bullosa
PITTSBURGH, March 27, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company developing “off-the-shelf” treatments for rare dermatological diseases, announces the ...
March 27, 2018
Caelum Biosciences Announces Updated Phase 1b Data Presented at 16th International Symposium on Amyloidosis
NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (FBIO) Company developing treatments for rare and life-threatening diseases, ...
March 27, 2018
Oncobiologics Appoints Dr. Joerg Windisch to Board of Directors
CRANBURY, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) today announced the appointment of Joerg Windisch, Ph.D. to its board of directors, effective ...
March 26, 2018
Prometic to report its Fourth Quarter and Year-End 2017 Financial Results and hold Conference Call / Webcast
LAVAL, QC, March 26, 2018 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic") announced today that it will report its financial results for the fourth ...
March 26, 2018
Heat Biologics Reports Positive Data to Further Support the Mechanism of Action for its Proprietary T-Cell Activation Platform
DURHAM, NC / ACCESSWIRE / March 26, 2018 / Heat Biologics, Inc. (HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system ...
March 26, 2018
Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors
JERUSALEM, March 26, 2018 /PRNewswire/ -- Intec Pharma LTD (NASDAQ, TASE: NTEC) ("Intec" or "the Company") today announces the appointment of Roger J. Pomerantz, M.D., F.A.C.P. ...
March 26, 2018
Catalyst Biosciences Receives $1.5 Million In Two Milestone Payments for Neuronal Nicotinic Receptor (NNR) Asset
SOUTH SAN FRANCISCO, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
March 26, 2018
Eiger Announces First Patient Dosed in Phase 2 PREVENT Study of Exendin 9-39 in Patients Suffering from Post-Bariatric Hypoglycemia
PALO ALTO, Calif., March 26, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of therapies for rare diseases, today announced the ...
March 26, 2018
ARMO BioSciences Announces Positive Outcome of First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study
REDWOOD CITY, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- ARMO BioSciences, Inc. (ARMO), a late-stage immuno-oncology company, today announced the completion of the first interim ...
March 26, 2018
Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
CRANBURY, N.J., March 26, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases ...
March 26, 2018
BioLife Solutions and SAVSU Technologies to be Awarded Second Patent for Next Generation Cold Chain Technologies Designed for Cell and Gene Therapies
BOTHELL, Wash. and ALBUQUERQUE, N.M., March 26, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue ...
March 26, 2018
Aeglea BioTherapeutics Appoints Dr. Ivana Magovčević-Liebisch to Board of Directors
AUSTIN, Texas, March 26, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
March 26, 2018
Advaxis Announces Four Poster Presentations Highlighting Lm-based Antigen Delivery Technology at AACR 2018
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that results from multiple preclinical ...
March 22, 2018
iCAD Reports Fourth Quarter and Full-Year 2017 Financial Results
NASHUA, N.H., March 22, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the ...
March 22, 2018
HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2017 Results
TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, ...
March 22, 2018
La Jolla Pharmaceutical Company Announces Launch of GIAPREZA™ (angiotensin II) in the United States
SAN DIEGO, March 22, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (LJPC) today announced that GIAPREZA™ (angiotensin II), injection for intravenous infusion, is now commercially ...
March 22, 2018
Altimmune to Participate at the H.C. Wainwright Global Life Sciences Conference
GAITHERSBURG, Md., March 22, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, ...
March 22, 2018
Celyad Reports 2017 Financial and Operating Results and Expected Key Milestones for 2018
Celyad (Euronext Brussels:CYAD) (CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today provides an update on its recent operations ...
March 22, 2018
Heron Therapeutics to Present at the 17th Annual Needham Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of ...
Page 65 of 127